candesartan drug pathway candesartan pharmacodynamics pathway 2015-10-29T13:43:43Z PW:0002130 SMP:00158 The pathway of candesartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug. pathway vpetri